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A B S T R A C T
Objectives: To compare multipotent mesenchymal stem cells (MSCs) obtained from chorionic villi (CV),
amniotic ﬂuid (AF) and placenta, with regard to their phenotype and gene expression, in order to
understand if MSCs derived from different extra-embryonic tissues, at different stages of human
ontological development, present distinct stemness characteristics.
Study design: MSCs obtained from 30 samples of CV, 30 of AF and 10 placentas (obtained from elective
caesarean sections) were compared. MSCs at second conﬂuence cultures were characterized by
immunophenotypic analysis with ﬂow cytometry using FACS CANTO II. The expression of the genes Oct-
4 (Octamer-binding transcription factor 4, also known as POU5F1), Sox-2 (SRY box-containing factor 2),
Nanog, Rex-1 (Zfp-42) and Pax-6 (Paired Box Protein-6), was analyzed. Real-time quantitative PCR was
performed by ABI Prism 7700, after RNA isolation and retro-transcription in cDNA. Statistical analysis
was performed using non-parametric test Kruskal–Wallis (XLSTAT 2011) and conﬁrmed by REST
software, to estimate fold changes between samples. Each gene was deﬁned differentially expressed if p-
value was <0.05.
Results: Cells from all samples were negative for haematopoietic antigens CD45, CD34, CD117 and CD33
and positive for the typical MSCs antigens CD13, CD73 and CD90. Nevertheless, MSCs from AF and
placentas showed different ﬂuorescence intensity, reﬂecting the heterogeneity of these tissues. The gene
expression of OCT-4, SOX-2, NANOG was not signiﬁcantly different among the three groups. In AF, REX-1
and PAX-6 showed a higher expression in comparison to CV.
Conclusions: MSCs of different extra-embryonic tissues showed no differences in immunophenotype
when collected from second conﬂuence cultures. The expression of OCT-4, NANOG and SOX-2 was not
signiﬁcantly different, demonstrating that all fetal sources are suitable for obtaining MSCs. These results
open new possibilities for the clinical use of MSCs derived from easily accessible sources, in order to
develop new protocols for clinical and experimental research.
 2013 Elsevier Ireland Ltd. All rights reserved.
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Stem cells are primitive non-specialized cells, able to regener-
ate themselves and to differentiate into speciﬁc cell types [1]. Stem
cells are classiﬁed as follows: totipotent, able to give rise to all cell
types of the organism, including extra-embryonic tissues [2,3];
pluripotent, able to differentiate into cell types derived from the
three germ layers but not into extra-embryonic tissues [4];
multipotent, capable of generating a limited number of cell types,* Corresponding author. Tel.: +39 091 6785537; fax: +39 091 6785522.
E-mail address: allegra@centroandros.it (A. Allegra).
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http://dx.doi.org/10.1016/j.ejogrb.2013.07.032restricted to a single germ layer [3]; unipotent, able to generate a
single cell type. They are found in various adult tissues [5].
Stem cells can also be classiﬁed into embryonic (ESCs) and adult
stem cells (ASCs) [6]. Both of these two cell types have some
limitations: ESCs are pluripotent and have a high grade of self-
renewal [7] but may form tumours and develop host immune
rejection [5]. Moreover, their use opens many ethical concerns.
ASCs are multipotent and have a lower differentiation and
proliferative potential than ESCs but do not present ethical
problems [3,5].
To overcome these limitations, many efforts have been made to
isolate stem cells from other sources [8]. On the one hand, patient-
speciﬁc pluripotent stem cells from specialized adult cells have
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stem cells) [7]; on the other hand, multipotent stem cells have
been isolated from the fetus but with high risk of morbidity, and
from extra-embryonic tissues (fetal membranes, placenta and
umbilical cord blood) [9]. Whereas umbilical cord blood is a source
of haematopoietic stem cells, extra-embryonic tissues are utilized
as an important source of stem cells with a high potential for
differentiation. Among the different populations, multipotent
mesenchymal stem cells (MSCs) represent a very promising tool
in clinical applications for their differentiating potential towards
mesoderm-derived lineage.
More than 120 clinical trials are in progress utilizing MSCs for
different therapeutic applications [10,11]. In clinical practice, the
main source of MSCs is adult bone marrow. The percentage of MSCs
in the bone marrow, however, is very low (0.001–0.01%), it
decreases with age [12] and the retrieval techniques are
dangerous. For these reasons it is important to ﬁnd alternative
sources of MSCs, such as extra-embryonic tissues [9] and adipose
tissue, which offers a greater number of cells and is easily
accessible [13,14].
Moreover, MSCs from extra-embryonic sources have interme-
diate characteristics between ESCs and ASCs [9,15]. In a recent
study, MSCs obtained from 10 samples of chorionic villi showed
multipotent properties in common with ESCs [16]. Although MSCs
have well-known characteristics [17], their differences among
different sources in terms of gene expression have not been
determined yet [18]. It should be really interesting to understand if
stem cell potential is reduced during human ontological develop-
ment.
This topic has been previously explored [19] but the originality
of our study derives from the contemporaneous analysis of the
three different samples at different stages of human development.
The rationale of this experimental study was to understand if MSCs
derived from different extra-embryonic tissues, at different stages
of human ontological development, presented different stemness
potential.
We analyzed the expression of the stem cell master genes OCT-4
(Octamer-binding transcription factor 4, also known as POU5F1),
SOX-2 (SRY box-containing factor 2) and NANOG in all samples.
Moreover, we evaluated the expression of two other genes, REX-1
(Zfp-42) and PAX-6 (Paired Box Protein-6), expressed by stem cells
under the control of Oct-4, Sox-2 and Nanog.
2. Materials and methods
In this experimental study, a comparison, in terms of phenotype
and gene expression, among three different extraembryonic
tissues – chorionic villi (CV), amniotic ﬂuid (AF) and placenta –
was carried out.
CV and AF samples were obtained from 30 pregnant women for
each group, aged 23–45 years, from the 11th to 14th and the 15th
to 21st weeks respectively. The patients underwent chorionic
villus sampling (CVS) and amniocentesis to look for chromosomal
abnormalities. The great majority of the samples analyzed came
from healthy pregnancies. Only 3 samples out of 60 (5%) had a
trisomy (trisomy 21). No difference in terms of immunophenotypic
and gene expression analysis was found between the healthy
pregnancies and those with chromosomal abnormalities. The
placental samples were obtained from 10 pregnant women, aged
25–39 years and derived from elective caesarean sections, carried
out around 38 weeks of gestation.
The study was approved by the local Ethics Committee (‘‘Ethics
Committee of ANDROS Day Surgery, Palermo, Approval date:
November 15, 2010, Reference number 03/MR/10’’).
CV was ﬁrst mechanically fragmented and then enzymatically
digested using pronase (Merck) and collagenase (Sigma) for 15 minfor both phases. Enzyme activity was arrested with Hank’s
Balanced Salts solution (Sigma). Cells were plated in non-coated
25 cm2 polystyrene culture ﬂasks in Chang Medium (Irvine
Scientiﬁc), a complete culture medium supplemented with
penicillin, streptomycin, amphotericin, 10% fetal bovine serum
(FBS) and glutamine (EuroClone).
AF samples, obtained from amniocentesis, were centrifuged at
1400 RPM for 10 min. Cells were then plated in non-coated 25 cm2
polystyrene culture ﬂasks in Chang Medium. All samples were
collected in order to carry out prenatal diagnosis and were then
used for the present study at the second passage of culture with the
consent of each woman.
Placenta samples were ﬁrst mechanically fragmented and then
enzymatically digested using pronase (Merck) and collagenase
(Sigma) for 30 min for each phase. Enzyme activity was arrested
with culture media containing FBS, cells were counted and 5  105
cells were plated in non-coated 25 cm2 polystyrene culture ﬂasks
in Chang Medium (Irvine Scientiﬁc). These samples were also
analyzed at the second passage of culture.
In order to conﬁrm the fetal origin of the placenta samples, a 16
autosomal STR DNA genotyping (D3S1358, D19S433, D2S1338,
D16S539, D18S51, TH01, D21S11, vWA, D8S1179, FGA, SE33,
D22S1045, D10S1248, D1S1656, D12S391, D2S441), carried out
using Powerplex 17 ESI System (Promega), was performed.
Flasks from all samples were stored at 37 8C in a CO2 incubator.
Regarding placenta samples, non-adherent cells were removed and
fresh medium was added after 48 h. Culture medium was replaced
twice a week in all samples and cells were replaced after reaching
80% (about every week) conﬂuence using trypsine/EDTA (Sigma).
MSCs were initially investigated for the spindle-shape morpholo-
gy, absence of contamination by pathogens and for their
proliferative potential in culture.
Cells from all samples were evaluated for cell surface antigens
expression by ﬂow cytometry, performed by FACS CANTO II (BD
Bioscience). Four lasers evaluated simultaneously the physical
parameters, Forward Scatter (FSC) and Side Scatter (SSC), and the
expression of six different surface antigens on a single tube. Cells
from all samples were collected at conﬂuence, pelleted, suspended
in 100 ml of PBS at the concentration of 1  104 cells/ml and stained
with the antibodies. Cells were incubated in the dark for 15 min at
room temperature. After incubation, cells were washed with PBS
and suspended in 100 ml of PBS to be analyzed with Facs Canto II.
Cells were incubated with the following antibodies: CD13-FITC
(Dako), CD90-PE (Beckman Coulter), CD73-PE, CD34- PerCP-CY5.5,
CD117- PE-CY7, CD33-APC and CD45-APC-CY7 (BD Biosciences).
Flow cytometer settings were established using unstained cells.
Cells were gated by FSC to eliminate debris. A minimum of 10,000
events was counted for each analysis. Some samples were assayed
by ﬂow cytometry at different culture passages to determine any
changes in surface molecule expression.
Cells in culture were treated with PBS and 2 RNA Nucleic Acid
Puriﬁcation Solution (Applied Biosystem) to lyse cells and preserve
RNA. Total RNA was extracted by the platform ABI PRISM 6100
Nucleic Acid PrepStation (Applied Biosystem). The RNA concen-
tration and purity were measured with a spectrophotometer by
determining the absorbance ratio of 260 nm to 280 nm (>1.8). To
assess the integrity, RNA fragments were resolved on a 1.2%
agarose gel looking for subunits18S and 28S of rRNA. 1 mg of total
RNA was then reverse-transcribed with High-Capacity cDNA
Archive kit (Applied Biosystem). The reaction was performed in
a thermocycler in a ﬁnal volume of 12 ml (10 min at 25 8C, 60 min
at 37 8C and 7 min at 4 8C).
Real-time quantitative PCR was conducted on a ABI Prism 7700
(Applied Biosystem). 2.5 ml of cDNA were added with the PCR
master mix (Applied Biosystem) and the speciﬁc primers and
probes (TaqMan Gene Expression Assay, Applied Biosystem). The
Table 1
Characteristics of the samples.
Samples Patients’ age
(mean  standard
deviation)
Gestational age
(mean  standard
deviation)
Chorionic villi (n = 30) 36.3  4.9 12.5  0.8
Amniotic ﬂuid (N = 30) 36.9 4.1 17.3 1.8
Placentas (n = 10) 32.4  4.7 38.2  0.3
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which checks the speciﬁcity of primers and probes.
Each sample of cDNA from different cell lines (CV, AF and
placentas) was ampliﬁed for the housekeeping gene GAPDH (code
hs99999905_m1) as relative gene and for genes OCT-4 (code
hs01895061_u1), SOX-2 (code hs01053049_s1), NANOG (code
hs02387400_g1), REX-1 (code hs01938187_s1) and PAX-6 (code
hs01088112_m1). For the elaboration of data, a relative quantiﬁ-
cation by calculating the difference between the target gene and
the control gene Ct was carried out. Reaction mix with water
instead of cDNA was used as negative control. The thermal protocol
used was: 10 min at 37 8C, 2 min at 50 8C and 10 min at 95 8C for 50
holds, 5 s at 95 8C and 60 8C forever.
Concerning statistical analysis, data from real-time quantitative
PCR were analyzed by the non-parametric Kruskal–Wallis test
using the software XLSTAT and then validated by the Relative
Expression Software Tool (REST), to estimate fold changes among
samples. Each gene was deﬁned with a different expression when
estimated p-value was <0.05. To increase the stability of the
results, we applied ﬁltering criteria that included mRNA, whichFig. 1. Flow cytometry analysis of mesenchymal stem cells from extra-embryonic tissues.
CD33 and CD45 and mesenchymal antigens CD13, CD90 and CD73. Boxes A, B, and C r
placentas). Box D is an example of AF sample which expresses the MSC markers CD73were reliably quantiﬁable (cut off <30 Ct for the housekeeping
gene). Undetermined values of Ct were estimated as 50 Ct (the last
cycle of the reactions).
3. Results
Thirty samples of CV and 30 samples of AF were obtained for
this study at the end of the second passage of culture and they were
tested after reaching the second conﬂuence. Ten placenta samples
were isolated from the fresh tissue and they were maintained in
culture up to the second conﬂuence in order to remove differences
among samples.
Table 1 indicates the mean age of the patients and the mean
week of sampling for each group. Four samples from all sources
were maintained in culture for over a month to evaluate the
behaviour of these cells. We observed that cells from different fetal
sources are easy to expand in vitro and show a ﬁbroblast-like
morphology, consistent with that of typical MSCs.
Fetal stem cells from all samples were ﬁrstly characterized by
ﬂow cytometry for the expression of 7 cell surface antigens (CD13,
CD90, CD73, CD34, CD117, CD33 and CD45) in order to better
characterize MSCs.
MSCs from CV, AF and placentas were clearly negative for the
expression of the haematopoietic surface antigens CD34, CD117,
CD33 and CD45, while they expressed the typical MSCs antigens
CD13, CD73 and CD90 at high ﬂuorescence intensity (Fig. 1, boxes
A, B, and C) [20]. Some samples of AF showed a speciﬁc cell
population which expressed the MSCs markers CD73 and CD90 at
different ﬂuorescence intensities (Fig. 1, box D). Furthermore, the
same heterogeneity was found for the placenta samples. Cells were investigated for the expression of haematopoietic antigens CD34, CD117,
epresent a sample of each speciﬁc tissue (box A for CV, box B for AF and box C for
 and CD90 at a different ﬂuorescence intensity.
Table 2
Mean (SEM) DCt values of chorionic villi, amniotic ﬂuid and placentas. A lower DCt indicates a higher expression of the speciﬁc gene.
Samples SOX-2 OCT-4 NANOG REX-1 PAX-6
Chorionic villi (n = 29) 12.46  3.34 10.58  1.47 11.23  2.42 16.38  2.68 19.85  2.77
Amniotic ﬂuid (n = 27) 11.26  2.84 10.61  2.13 11.27  2.89 12.9  0.72 14.45  3.45
Placentas (n = 6) 11.69  2.68 8.6  1.69 11  1.45 14.82  2.48 15.86  1.10
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passages of culture, indicating that MSCs phenotypic characteristics
are not lost during different phases of cultures (data not shown).
Real-time PCR was performed on 30 CV samples, 30 AF samples
and 10 placenta samples at the end of the second conﬂuence. The
expression of the ﬁve genes investigated, OCT-4, SOX-2, NANOG,
REX-1 and PAX-6, was related to the expression of the housekeep-
ing gene GAPDH which indicates the success of cDNA synthesis.
Some samples were discarded for statistical analysis because of the
poor quality of the real-time PCR data. As a result of these
limitations, 29 samples of CV, 27 samples of AF and 6 samples of
placenta were used for gene expression analysis.
We estimated the DCt as the difference between Ct of each
target gene and Ct of GAPDH, as control gene. A lower DCt indicates
a higher expression of the gene and a higher DCt indicates a lower
expression of the gene. The expression of the ﬁve genes analyzed
was quite heterogeneous among samples within the same fetal
source. Table 2 summarizes the mean DCt values of the three
sources obtained from real-time PCR.
The Kruskal–Wallis test showed that there were no signiﬁcant
differences in terms of gene expression among all MSCs for the
master genes OCT-4 (p-value = 0.15), SOX-2 (p-value = 0.32) and
NANOG (p-value = 0.89), whereas REX-1 and PAX-6 genes were
found to be differently expressed among CV, AF and placenta
samples in terms of median with statistical signiﬁcance (p-
value = 0.04 for PAX-6 and p-value = 0.02 for REX-1).
Comparisons among groups were conducted by the software
REST. Graphical output of the results is presented in the box plotsFig. 2. The results were obtained by the software REST. Box A shows a signiﬁcant negative
asymmetry indicates that the gene expression of REX-1 was higher in AF samples. Box B
‘control group’ (p = 0.0001). This negative asymmetry indicates a higher expression of (Fig. 2). In order to interpret these, it is important to keep in mind
that a greater asymmetry in the position of the box in respect to the
whiskers represents a greater difference in gene expression.
Expression of genes REX-1 and PAX-6 was found signiﬁcantly
higher in AF samples (p = 0.004 for REX-1 and p = 0.0001 for PAX-6)
compared with CV samples (substantial negative asymmetry).
Expression of REX-1 and PAX-6 was higher in AF compared with
placenta samples (slight negative asymmetry) and lower in CV
samples compared with the placenta samples (slight positive
asymmetry). In both cases these differences did not achieve
signiﬁcance (p-value = 0.081 for REX-1 and p-value = 0.414 for PAX-
6 for AF vs placenta; p-value = 0.641 for REX-1 and p-value = 0.123
for PAX-6, for CV vs placenta).
Moreover, no signiﬁcant changes in gene expression proﬁle
were observed by maintaining some samples in culture for over a
month (Fig. 3).
4. Comments
As far as we know, this paper represents the ﬁrst comparison
among MSCs derived from different extra-embryonic tissues at
different stages of human development. These MSCs showed no
differences in morphology and growth characteristics when
maintained in culture under the same conditions.
Some samples of AF and placenta showed a heterogeneous
phenotype as demonstrated by ﬂow cytometry in which AF and
placenta samples expressed CD73 and CD90 at different ﬂuores-
cence intensity. asymmetry for REX-1 in CV samples, using AF as the ‘control group’ (p = 0.004). This
 shows a signiﬁcant negative asymmetry for PAX-6 in CV samples, using AF as the
PAX-6 in AF samples.
Fig. 3. Gene expression proﬁle of a sample of AF (A) and a sample of CV (B)
maintained in culture for over a month. DCt was estimated as the difference
between each target gene Ct and GAPDH Ct. No signiﬁcant difference was observed
for gene expression proﬁle.
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origin [21], consisting of multiple cell types derived from fetal and
maternal tissues [22,23]. In particular, AF cells derive from both
extra-embryonic and embryonic tissues [24]. The general consen-
sus is that AF cells mainly consist of fetal cells shed in the amniotic
cavity from the developing skin, respiratory apparatus, urinary and
gastrointestinal tracts [25].
Cells from all samples were analyzed for the expression of OCT-
4, SOX-2, NANOG, REX-1 and PAX-6 genes, which are important for
the maintenance of stem potential [26,27]. The differences in
expression of OCT-4, SOX-2 and NANOG genes were not signiﬁcant,
demonstrating that all fetal sources are equally suitable for
obtaining MSCs.
An up-regulation was found for REX-1 and PAX-6 genes in the AF
compared to CV.
REX-1 is a gene expressed in ESCs and its expression appears to
be regulated by Oct-4, Sox-2 and Nanog. Rex-1 is a marker for a
subpopulation of undifferentiated embryonic cells [28] and acts to
reduce differentiation in ESCs [29]. Furthermore, REX-1 expression
in mice decreases at the beginning of differentiation, during the
embryo development [30]. The higher signiﬁcant expression of this
gene in AF samples could be related to the capacity of limiting the
differentiation of MSCs. In the period of ontological development in
which amniocentesis is carried out, the differentiation process is
progressively reducing and this phenomenon could explain the
signiﬁcant higher expression of REX-1 in AF (p = 0.004) in
comparison with CV. On the other hand, during the period at
which CVS is performed, the differentiation process is entirely
active and REX-1 expression is consequently low. REX-1 expression
is also higher in placentas compared with CV, though without
statistical signiﬁcance.
PAX-6 is a master gene involved in ectodermal differentiation,
particularly in the development of the eye [31]. The development
of the eye temporally coincides with the amniocentesis and this
could be the reason of its higher expression in AF samples. The
temporally limited expression of PAX-6 is also, indirectly,
demonstrated by the fact that placenta samples show lower
expression of this gene, with a trend towards the statistical
signiﬁcance, in comparison to AF (Table 2). We believe that PAX-6expression is not enhanced in placenta as the eye has already
developed.
Thus, the evidence of a higher expression in AF of REX-1 and
PAX-6 may be correlated to a more advanced gestational age, in
which these genes are activated.
The non-signiﬁcance of the three master genes (OCT-4, SOX-2
and NANOG), among the different tissues, is an unexpected result.
This ﬁnding, however, is important experimental knowledge
which can allow the clinical use of those MSCs derived from the
simplest achievable source, which could be the placenta, as this is a
discarded tissue.
Our experimental results need to be conﬁrmed and validated in
larger studies but we believe that the ﬁeld of MSCs obtained from
extra-embryonic tissues should be expanded for future possible
applications in regenerative medicine.
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